We answer vaccine questions head-on, using real numbers to separate online fear from how vaccines, immunity, and public health actually work. We break down why diseases feel “gone,” what the modern schedule really exposes babies to, and how to spot misleading claims around ingredients, autism, and VAERS. Featuring Kate Moloney and our vaccine-hesitant friend Anah.

• why vaccine success makes diseases look eradicated while risk returns when coverage drops
• Stanford modeling estimates for measles, diphtheria, polio, and rubella without vaccination
• meningococcal meningitis basics, who is most at risk, and why outcomes can be catastrophic
• why clean water and sanitation do not explain protection from droplet-spread viruses
• what antigens are and why antigen exposure is far lower than decades ago
• downsides of delaying vaccines including longer vulnerability and more office visits
• aluminum, formaldehyde, and mercury claims explained with real-world comparisons
• “natural immunity” tradeoffs including measles pneumonia, immune amnesia, and SSPE
• long flu and post-viral inflammatory syndromes as quality-of-life consequences
• how vaccine schedules change, why the autism claim is debunked, and what profit incentives really look like
• what VAERS can and cannot tell you, plus how bias and viral claims distort reports
• why newborn hepatitis B vaccination exists, screening gaps, and true serious side effects
• rubella history and why vaccination primarily protects fetuses

1:05 Do We Vaccinate Too Much

3:32 Modeling A World Without Vaccines

6:20 Meningitis And Fast Catastrophes

8:28 Clean Water Is Not A Vaccine

11:02 Antigens And The Modern Schedule

15:44 Why Spacing Shots Can Backfire

16:53 Aluminum Formaldehyde Mercury Facts

22:00 Natural Immunity And Measles Damage

26:16 Long Flu And Post Viral Illness

28:26 Profit Fears And Autism Claims

31:26 VAERS Limits And Bad Math

38:39 Why Newborns Get Hepatitis B

45:09 Real Side Effects And Detox Scams

48:37 Rubella And Protecting Fetuses

51:57 Final Takeaways And Next Steps

Be sure to check out thinkingaoutobgyn.com for more information and be sure to follow us on Instagram.

Follow us on Instagram @thinkingaboutobgyn.

We take on four stubborn myths in modern obstetrics and follow the evidence instead of the vibes, from thrombophilia testing to bed rest to seizure prophylaxis. We also spotlight a patient-empowering insulin strategy that may improve gestational diabetes outcomes faster than usual care.
• distinguishing recurrent pregnancy loss evaluation from venous thromboembolism testing
• focusing thrombophilia workups on antiphospholipid antibody syndrome when criteria are met
• explaining why MTHFR variants and PAI-1 polymorphisms do not belong in routine panels
• unpacking how social media and narrative fallacies keep low-value tests alive
• reviewing the AWARE trial and why activity restriction lacks benefit and carries harms
• clarifying reasonable pregnancy activity modifications versus false labor prevention claims
• assessing late preterm antenatal corticosteroids for twins and the hypoglycemia signal
• discussing inertia of practice and why weak evidence becomes hard to undo
• breaking down patient-led insulin titration for gestational diabetes and why it may reduce macrosomia
• evaluating laboring down and long-term pelvic floor outcomes plus statistical pitfalls
• answering a listener question on Keppra alternatives to magnesium for preeclampsia seizures
Be sure to check out thinking about obgyn.com for more information, and be sure to follow us on Instagram.

0:00 Welcome And What We’re Reviewing

0:28 Thrombophilia Testing After Miscarriage

3:51 What Belongs In A VTE Panel

5:55 MTHFR And PAI1 Myth Busting

13:36 Activity Restriction And The AWARE Trial

23:27 Practical Counseling Without False Promises

27:08 Late Preterm Steroids For Twins

32:53 Patient-Led Insulin Titration In GDM

38:38 Laboring Down And Pelvic Floor Outcomes

47:51 Keppra Versus Magnesium For Preeclampsia

1:00:25 Wrap Up And Where To Follow

Follow us on Instagram @thinkingaboutobgyn.

We talk with Dr. Emily Donelan about how conflicting labor management guidelines can derail communication between nurses and physicians and quietly raise patient safety risks. We map the biggest friction points and lay out practical ways to reconcile guidance locally while pushing for a unified national approach.

• defining “communication dystocia” and why guideline discrepancies create real bedside conflict
• how evidence gaps drive teams toward institutional culture and inertia in practice
• the ARRIVE trial as a case study in differing priorities and framing
• a detailed induction vignette showing where amniotomy, oxytocin titration and uterine activity definitions collide
• why the 20 mU/min oxytocin threshold persists and what newer data suggests
• tachysystole rules, Category II tracings and how prescriptive language shapes nursing behavior
• delayed pushing versus pushing at complete dilation and the moral distress it can create
• the need for standardized evidence grading and cleaner citations across organizations
• a national interprofessional reconciliation program and who must be at the table
• one actionable step for tomorrow: stay curious and surface the real reason behind the disagreement

Be sure to check out thinking about obgyn.com for more information and be sure to follow us on Instagram.

0:01 Why Guideline Conflicts Matter

3:52 The ARRIVE Trial Framing Problem

12:23 A Labor Case Where Rules Collide

24:08 Oxytocin Thresholds And Litigation Fear

33:26 Pushing Timing And Moral Distress

38:05 Who Should Write Unified Guidance

44:04 Evidence Grading And Bedside Decisions

52:05 Inertia In Practice And De-Implementation

1:00:14 Takeaways Plus A No-Evidence Pet Peeve

Follow us on Instagram @thinkingaboutobgyn.